Apogee Therapeutics
1 follower
‌
Apogee Therapeutics, Inc. is a biotechnology company advancing novel therapies to address patients’ needs. Based in San Francisco and backed by leading life sciences funds, the company expects its lead pipeline program to enter clinical trials in 2023.
Industries
Headquarters
Employees
Links
Org chart
Michael Henderson
Chief Executive Officer at Apogee Therapeutics
Michael Henderson
Collapse
Carl Dambkowski
Chief Medical Officer
Dan Mulreany
Senior Vice President, Business Development and Strategy
Drew Badger
Senior Vice-President, Regulatory Affairs & Toxicology
Emily K Cox
Vp, Head Of People
Jane Pritchett Henderson
Chief Financial Officer
Wendy Aspden-Curran
Senior Vice President, Clinical Operations
Jordan Adajar
Director, Regulatory Affairs
Mehrak Kiankarimi
Senior Vice President, Operations and Program Management
Kristine Nograles
SVP, Clinical Development
Nimish Shah
Co-Founder and Board Director
Elizabeth W.
Senior Vice President, Quality Assurance
Tim Piringer
Senior Vice President, IT
Lukas Dillinger
Vice President, Research and Translational Medicine
Rebecca Dabora, PhD
Chief Technical Officer
Jeff Hartness
Chief Commercial Officer
